UPS
63
2
EW
20
4
OXY
36
-4
T
59
3
EXPE
81
3
KMB
45
3
CAH
50
2
ILMN
46
6
DOV
69
5
PPG
74
6
OI
43
6
ZTS
60
4
USB
53
10
BIIB
38
10
ACN
74
13
NTAP
64
3
COP
40
-7
NI
63
-2
CCI
33
-16
DAL
72
6
UPS
63
2
EW
20
4
OXY
36
-4
T
59
3
EXPE
81
3
KMB
45
3
CAH
50
2
ILMN
46
6
DOV
69
5
PPG
74
6
OI
43
6
ZTS
60
4
USB
53
10
BIIB
38
10
ACN
74
13
NTAP
64
3
COP
40
-7
NI
63
-2
CCI
33
-16
DAL
72
6
Financhill
Back

Elekta AB Vs. Keros Therapeutics Industry Stock Comparison

Sell
20

EKTAF
Elekta AB

Last Price:
6.25
Seasonality Move:
-0.33%
Buy
62

KROS
Keros Therapeutics

Last Price:
56.44
Seasonality Move:
54.08%
Sell
20
Elekta AB (EKTAF) is a Sell

Is Elekta AB a Buy, Sell or Hold?

  • The current Elekta AB [EKTAF] share price is $6.25. The Score for EKTAF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • EKTAF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EKTAF Stock Price Chart

What is Elekta AB's stock price today?

  • The Elekta AB share price today is $6.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EKTAF is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $56.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.

EKTAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 33.32 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.2 - 6.6) Sell
Bollinger Bands (100): (6.06 - 7.3) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.17 Buy
Relative Strength Index (14 RSI): 64.2 Buy
Chaikin Money Flow: -162874 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.46 - 56.8) Buy
Bollinger Bands (100): (45.02 - 53.82) Buy

EKTAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.25 Sell
20-day SMA: 6.33 Sell
50-day SMA: 6.31 Sell
200-day SMA: 7.14 Sell
8-day EMA: 6.26 Sell
20-day EMA: 6.31 Sell
50-day EMA: 6.4 Sell
200-day EMA: 6.93 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.92 Buy
20-day SMA: 53.86 Buy
50-day SMA: 50.03 Buy
200-day SMA: 52.7 Buy
8-day EMA: 55.87 Buy
20-day EMA: 53.93 Buy
50-day EMA: 51.33 Buy
200-day EMA: 49.85 Buy

Elekta AB Earnings Growth & EKTAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.

Elekta AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):